Brief: Incyte, Syndax Get FDA Approval For Niktimvo (axatilimab-csfr)

Syndax Pharmaceuticals

14/08/2024 22:42

Aug 14 (Reuters) - Incyte Corp  INCY.O :
    * INCYTE AND SYNDAX ANNOUNCE U.S. FDA APPROVAL OF NIKTIMVO™
(AXATILIMAB-CSFR) FOR THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST
DISEASE (GVHD)

Source text for Eikon:  ID:nBw712pWHa 
Further company coverage:  INCY.O 

 ((Reuters.Briefs@thomsonreuters.com;))